182 related articles for article (PubMed ID: 25978851)
1. Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10.
Cui C; Feng H; Shi X; Wang Y; Feng Z; Liu J; Han Z; Fu J; Fu Z; Tong H
Int Immunopharmacol; 2015 Jul; 27(1):110-21. PubMed ID: 25978851
[TBL] [Abstract][Full Text] [Related]
2. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
[TBL] [Abstract][Full Text] [Related]
3. Ganoderma lucidum polysaccharides antagonize the suppression on lymphocytes induced by culture supernatants of B16F10 melanoma cells.
Sun LX; Lin ZB; Duan XS; Lu J; Ge ZH; Li XJ; Li M; Xing EH; Jia J; Lan TF; Li WD
J Pharm Pharmacol; 2011 May; 63(5):725-35. PubMed ID: 21492175
[TBL] [Abstract][Full Text] [Related]
4. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
[TBL] [Abstract][Full Text] [Related]
5. Hypothermic microenvironment plays a key role in tumor immune subversion.
Du G; Liu Y; Li J; Liu W; Wang Y; Li H
Int Immunopharmacol; 2013 Oct; 17(2):245-53. PubMed ID: 23831011
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
[TBL] [Abstract][Full Text] [Related]
7. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
8. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
9. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
Hsiao YW; Liao KW; Chung TF; Liu CH; Hsu CD; Chu RM
Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
[TBL] [Abstract][Full Text] [Related]
10. Ribozyme to TGF-beta1 mRNA abrogates immunosuppressive effects of human colorectal adenocarcinoma HRT-18 cells in vitro and in vivo.
Schmitt WD; Siegert A; Lach SS; Fuhrmann S; Kondla A; Holm PS; Hauptmann S
Int J Oncol; 2009 Oct; 35(4):901-8. PubMed ID: 19724928
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta.
Lee HM; Kim KS; Kim J
Cell Immunol; 2014 Jul; 290(1):52-61. PubMed ID: 24879062
[TBL] [Abstract][Full Text] [Related]
12. Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction.
Yu L; Yang F; Jiang L; Chen Y; Wang K; Xu F; Wei Y; Cao X; Wang J; Cai Z
Eur J Immunol; 2013 Sep; 43(9):2461-72. PubMed ID: 23716181
[TBL] [Abstract][Full Text] [Related]
13. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
Eriksson M; Meadows SK; Wira CR; Sentman CL
J Leukoc Biol; 2004 Sep; 76(3):667-75. PubMed ID: 15178706
[TBL] [Abstract][Full Text] [Related]
14. Pathogen-expanded CD11b+ invariant NKT cells feedback inhibit T cell proliferation via membrane-bound TGF-β1.
Han Y; Jiang Z; Chen Z; Gu Y; Liu Y; Zhang X; Cao X
J Autoimmun; 2015 Apr; 58():21-35. PubMed ID: 25592391
[TBL] [Abstract][Full Text] [Related]
15. Systemic and local immunosuppression in pancreatic cancer patients.
von Bernstorff W; Voss M; Freichel S; Schmid A; Vogel I; Jöhnk C; Henne-Bruns D; Kremer B; Kalthoff H
Clin Cancer Res; 2001 Mar; 7(3 Suppl):925s-932s. PubMed ID: 11300493
[TBL] [Abstract][Full Text] [Related]
16. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response?
Razmkhah M; Jaberipour M; Erfani N; Habibagahi M; Talei AR; Ghaderi A
Cell Immunol; 2011; 266(2):116-22. PubMed ID: 20970781
[TBL] [Abstract][Full Text] [Related]
17. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 promotes the antitumor ability of natural killer cells in colorectal cancer via the miR-574-3p/TGF-β1 axis.
Li YP; Du XR; Zhang R; Yang Q
Bioengineered; 2021 Dec; 12(1):763-778. PubMed ID: 33660570
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
20. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
